We are live on ! Find out more
AFC

Ares Financial Consulting Portfolio holdings

AUM $139M
This Fund
S&P 500
This Quarter Est. Return
+12.94%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$139M
AUM Growth
+$12.1M
Cap. Flow
+$897K
Cap. Flow %
0.64%
Top 10 Hldgs %
40.89%
Holding
1,171
New
105
Increased
235
Reduced
84
Closed
39
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XENE icon
1051
Xenon Pharmaceuticals
XENE
$6.19B
$724 ﹤0.01%
+12
New +$666
ACM icon
1052
Aecom
ACM
$9.63B
$716 ﹤0.01%
10
TEAM icon
1053
Atlassian
TEAM
$28.8B
$700 ﹤0.01%
9
-59
-87% -$4.83K
BCC icon
1054
Boise Cascade
BCC
$2.96B
$699 ﹤0.01%
9
GFL icon
1055
GFL Environmental
GFL
$14.9B
$699 ﹤0.01%
19
COGT icon
1056
Cogent Biosciences
COGT
$7.22B
$697 ﹤0.01%
+18
New +$630
AOS icon
1057
A.O. Smith
AOS
$8.59B
$690 ﹤0.01%
11
CHRD icon
1058
Chord Energy
CHRD
$7.32B
$686 ﹤0.01%
6
XP icon
1059
XP
XP
$8.77B
$683 ﹤0.01%
42
CRL icon
1060
Charles River Laboratories
CRL
$12.6B
$680 ﹤0.01%
3
LEA icon
1061
Lear
LEA
$8.34B
$670 ﹤0.01%
5
ORKA
1062
Oruka Therapeutics
ORKA
$5.86B
$666 ﹤0.01%
+7
New +$466
SHC icon
1063
Sotera Health
SHC
$5.13B
$657 ﹤0.01%
+37
New +$583
SITC icon
1064
SITE Centers
SITC
$172M
$656 ﹤0.01%
165
ADAM
1065
Adamas Trust
ADAM
$848M
$647 ﹤0.01%
69
COO icon
1066
Cooper Companies
COO
$14.6B
$645 ﹤0.01%
+9
New +$588
ATEN icon
1067
A10 Networks
ATEN
$2.22B
$635 ﹤0.01%
+17
New +$494
PEN icon
1068
Penumbra
PEN
$12.7B
$632 ﹤0.01%
+2
New +$648
STE icon
1069
Steris
STE
$22.7B
$632 ﹤0.01%
+3
New +$643
EQNR icon
1070
Equinor
EQNR
$90.6B
$628 ﹤0.01%
20
PCTY icon
1071
Paylocity
PCTY
$8.18B
$627 ﹤0.01%
+6
New +$639
NAVI icon
1072
Navient
NAVI
$880M
$613 ﹤0.01%
72
BE icon
1073
Bloom Energy
BE
$69B
$605 ﹤0.01%
2
SRRK icon
1074
Scholar Rock
SRRK
$5.74B
$605 ﹤0.01%
+11
New +$531
SMCI icon
1075
Super Micro Computer
SMCI
$19.6B
$587 ﹤0.01%
20
-100
-83% -$3.19K

Similar funds

Ares Financial Consulting's Q2 2026 Portfolio in Review

As of Q2 2026, Ares Financial Consulting held 1,171 positions worth $139M, up 9.5% from $127M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Ares Financial Consulting's Q2 2026 filing shows 105 new, 235 increased, 84 reduced and 39 closed positions. Its largest new stake was AstraZeneca: 486 shares worth $92.2K. The largest sale was Dimensional US Core Equity Market ETF, an estimated $443K.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Communication Services and Industrials.

  • Ares Financial Consulting's largest Q2 2026 buy was AstraZeneca: 486 shares worth $92.2K.
  • Ares Financial Consulting added most to PIMCO 15+ Year US TIPS Index Exchange-Traded Fund in Q2 2026, an estimated $567K increase.
  • Ares Financial Consulting's biggest Q2 2026 reduction was Dimensional US Core Equity Market ETF, cutting an estimated $443K.
  • Ares Financial Consulting fully exited Vanguard FTSE All-World ex-US ETF in Q2 2026, selling an estimated $203K.
  • Ares Financial Consulting's ten largest holdings make up 41% of its $139M portfolio in Q2 2026.
  • Ares Financial Consulting opened 105 new positions and closed 39 in Q2 2026.
  • Ares Financial Consulting's portfolio value rose 9.5% quarter-over-quarter to $139M.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.